Cautionary note on the use of the B subunit of cholera toxin as a ganglioside GM1 probe: detection of cholera toxin A subunit in B subunit preparations by a sensitive adenylate cyclase assay
- PMID: 2156874
- DOI: 10.1002/jcb.240420305
Cautionary note on the use of the B subunit of cholera toxin as a ganglioside GM1 probe: detection of cholera toxin A subunit in B subunit preparations by a sensitive adenylate cyclase assay
Abstract
The use of the B subunit of cholera toxin, a protein that binds specifically to ganglioside GM1, has provided a new paradigm for studying physiological functions of ganglioside GM1. The B subunit inhibited the growth of rat glioma C6 cells that had been pretreated with ganglioside GM1. In some preparations of the B subunit, the inhibition was independent of adenylate cyclase activation and was due to the binding of the B subunit to ganglioside GM1 inserted onto the cell surface. However, in other preparations of the B subunit, there was an additional inhibitory effect due to small contaminations with the A subunit, which caused increases in intracellular cyclic adenosine monophosphate (cAMP) levels and concomitant growth inhibition. This vanishingly small contamination with the A subunit could not be detected by conventional protein sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis but could be measured utilizing a sensitive adenylate cyclase activation assay. Thus caution must be used to ensure that any biological effects of the B subunit are not due to contaminating A subunit and are due solely to the binding of the B subunit to ganglioside GM1 exposed on the cell surface. This is especially important in cyclic nucleotide-sensitive systems.
Similar articles
-
Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.J Immunol. 1992 Apr 1;148(7):1999-2005. J Immunol. 1992. PMID: 1312102
-
cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation.J Immunol. 1990 Nov 15;145(10):3162-9. J Immunol. 1990. PMID: 2172379
-
Insertion of ganglioside GM1 into rat glioma C6 cells renders them susceptible to growth inhibition by the B subunit of cholera toxin.Biochim Biophys Acta. 1988 May 13;969(3):249-56. doi: 10.1016/0167-4889(88)90059-6. Biochim Biophys Acta. 1988. PMID: 2835987
-
[Cholera research 100 years after its discovery--current topics].Nihon Saikingaku Zasshi. 1984 Jul;39(4):713-31. Nihon Saikingaku Zasshi. 1984. PMID: 6094878 Review. Japanese. No abstract available.
-
The nature and action of cholera toxin.Ciba Found Symp. 1976;(42):73-88. doi: 10.1002/9780470720240.ch5. Ciba Found Symp. 1976. PMID: 791600 Review.
Cited by
-
Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.Immunology. 1998 May;94(1):22-7. doi: 10.1046/j.1365-2567.1998.00482.x. Immunology. 1998. PMID: 9708182 Free PMC article.
-
GM1 Ganglioside: Past Studies and Future Potential.Mol Neurobiol. 2016 Apr;53(3):1824-1842. doi: 10.1007/s12035-015-9136-z. Epub 2015 Mar 12. Mol Neurobiol. 2016. PMID: 25762012 Review.
-
Sphingosine-1-phosphate: From insipid lipid to a key regulator.J Biol Chem. 2020 Mar 6;295(10):3371-3384. doi: 10.1074/jbc.X120.012838. J Biol Chem. 2020. PMID: 32144147 Free PMC article.
-
Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.J Neurovirol. 2016 Dec;22(6):774-788. doi: 10.1007/s13365-016-0451-6. Epub 2016 May 12. J Neurovirol. 2016. PMID: 27173397 Free PMC article.
-
Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity.J Exp Med. 1997 Apr 7;185(7):1203-10. doi: 10.1084/jem.185.7.1203. J Exp Med. 1997. PMID: 9104807 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources